Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
$9.73
0.0%
$9.66
$8.73
$10.15
N/AN/A38,881 shs53,250 shs
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
$2.73
-0.4%
$2.94
$1.73
$4.23
$464.55M3.275.06 million shs7.43 million shs
California Business Bank stock logo
CABB
California Business Bank
$0.01
$0.01
$0.01
$0.01
$1.29M0.59N/AN/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
0.00%0.00%0.00%0.00%+2.15%
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
-0.36%-21.33%-4.21%-9.30%+56.90%
California Business Bank stock logo
CABB
California Business Bank
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
$9.73
0.0%
$9.66
$8.73
$10.15
N/AN/A38,881 shs53,250 shs
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
$2.73
-0.4%
$2.94
$1.73
$4.23
$464.55M3.275.06 million shs7.43 million shs
California Business Bank stock logo
CABB
California Business Bank
$0.01
$0.01
$0.01
$0.01
$1.29M0.59N/AN/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
0.00%0.00%0.00%0.00%+2.15%
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
-0.36%-21.33%-4.21%-9.30%+56.90%
California Business Bank stock logo
CABB
California Business Bank
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
0.00
N/AN/AN/A
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
2.75
Moderate Buy$15.33461.66% Upside
California Business Bank stock logo
CABB
California Business Bank
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ISG, BTA, CABA, and CABB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
Reiterated RatingBuy$16.00
8/24/2026
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
UpgradeStrong-Buy
8/14/2026
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
Lower Price TargetEqual Weight$4.00 ➝ $3.00
7/17/2026
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
Reiterated RatingSell (D-)
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
-$7.69MN/AN/AN/AN/AN/A
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
N/AN/AN/AN/A$1.16 per shareN/A
California Business Bank stock logo
CABB
California Business Bank
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
-$167.86M-$1.57N/AN/AN/AN/A-128.27%-95.47%11/9/2026 (Estimated)
California Business Bank stock logo
CABB
California Business Bank
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest ISG, BTA, CABA, and CABB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
-$0.3729-$0.34+$0.0329-$0.34$1.67 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
$0.495.04%N/AN/AN/A
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
N/AN/AN/AN/AN/A
California Business Bank stock logo
CABB
California Business Bank
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
N/AN/AN/A
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
N/A
5.79
5.79
California Business Bank stock logo
CABB
California Business Bank
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Long-Term Municipal Advantage Trust stock logo
BTA
BlackRock Long-Term Municipal Advantage Trust
N/AN/AN/ANot Optionable
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
50169.55 million158.63 millionOptionable
California Business Bank stock logo
CABB
California Business Bank
N/A141.96 millionN/ANot Optionable

New MarketBeat Followers Over Time

Media Sentiment Over Time

BlackRock Long-Term Municipal Advantage Trust stock logo

BlackRock Long-Term Municipal Advantage Trust NYSE:BTA

BlackRock Long-Term Municipal Advantage Trust is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets of the United States. It uses financial derivatives to invest in municipal obligations. The fund primarily invests in long-term municipal bonds with a maturity of more than ten years at the time of investment. BlackRock Long-Term Municipal Advantage Trust was formed on February 28, 2006 and is domiciled in United States.

Cabaletta Bio stock logo

Cabaletta Bio NASDAQ:CABA

$2.73 -0.01 (-0.36%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.78 +0.05 (+1.83%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, which is in Phase I/II clinical trial for the treatment of mucosal pemphigus vulgaris; and MuSK-CAART, an investigational cell therapy that is in Phase I/II clinical trial for treating patients with anti- muscle-specific kinase antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

California Business Bank stock logo

California Business Bank OTCMKTS:CABB

$0.0091 0.00 (0.00%)
As of 09/4/2026

California Business Bank provides various financial products and services for small businesses and entrepreneurs. The company offers various personal and business deposit products; and business and commercial loans comprising SBA, commercial and industrial, and commercial real estate loans. It also provides online and mobile banking, mobile deposit, bill pay, and other services. The company was founded in 2005 and is headquartered in Irvine, California.